Aggravation of post-ischemic liver injury by overexpression of insulin-like growth factor binding protein 3

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhou, Lu ^a,b   Koh, Hyoung Won ^b   Bae, Ui Jin ^b   Park, Byung Hyun ^b  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADENOVIRIDAE; ANIMAL; APOPTOSIS; BLOOD; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HEP-G2 CELL LINE; HUMAN; INDUCED HYPOTHERMIA; ISCHEMIC PRECONDITIONING; LIVER; MALE; METABOLISM; MOUSE; NECROSIS; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSGENE;

ACETYLCYSTEINE; ADENOVIRIDAE; ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HEP G2 CELLS; HUMANS; HYPOTHERMIA, INDUCED; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; ISCHEMIC PRECONDITIONING; LIVER; MALE; MICE; MICE, INBRED C57BL; NECROSIS; NEUTROPHIL INFILTRATION; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSGENES;

EID: 84931274887     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11231     Document Type: Article

References (36)

1. Casillas-Ramirez, A., Mosbah, I. B., Ramalho, F., Rosello-Catafau, J. & Peralta, C. Past and future approaches to ischemiareperfusion lesion associated with liver transplantation. Life Sci. 79, 1881-1894; doi:10.1016/j.lfs.2006.06.024 (2006).
2. Jaeschke, H. Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts. J. Gastroenterol. Hepatol. 26 Suppl 1, 173-179; doi:10.1111/j.1440-1746.2010.06592.x (2011).
3. He, S. Q. et al. Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver Transpl. 12, 1869-1879; doi:10.1002/lt.21001 (2006).
4. Yu, J. et al. Aggravation of post-ischemic liver injury by overexpression of A20, an NF B suppressor. J. Hepatol. 55, 328-336; doi:10.1016/j.jhep.2010.11.029 (2011).
5. Jaeschke, H. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemiareperfusion and other acute inflammatory conditions. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1083-1088; doi:10.1152/ajpgi.00568.2005 (2006).
6. Elias-Miro, M., Jimenez-Castro, M. B., Rodes, J. & Peralta, C. Current knowledge on oxidative stress in hepatic ischemia/reperfusion. Free Radic. Res. 47, 555-568; doi:10.3109/10715762.2013.811721 (2013).
7. Peralta, C., Jimenez-Castro, M. B. & Gracia-Sancho, J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J. Hepatol. 59, 1094-1106; doi:10.1016/j.jhep.2013.06.017 (2013).
8. Harada, N., Okajima, K., Kurihara, H. & Nakagata, N. Antithrombin prevents reperfusion-induced hepatic apoptosis by enhancing insulin-like growth factor-I production in mice. Crit. Care Med. 36, 971-974; doi:10.1097/CCM.0B013E3181653642 (2008).
9. Harada, N., Zhao, J., Kurihara, H., Nakagata, N. & Okajima, K. Stimulation of Fc RI on primary sensory neurons increases insulin-like growth factor-I production, thereby reducing reperfusion-induced renal injury in mice. J. Immunol. 185, 1303-1310; doi:10.4049/jimmunol.0902051 (2010).
10. Prele, C. M. et al. Insulin-like growth factor-1 overexpression in cardiomyocytes diminishes ex vivo heart functional recovery after acute ischemia. Cardiovasc. Pathol. 21, 17-27; doi:10.1016/j.carpath.2010.11.008 (2012).
11. Vivar, R. et al. Cardiac fibroblast death by ischemia/reperfusion is partially inhibited by IGF-1 through both PI3K/Akt and MEKERK pathways. Exp. Mol. Pathol. 93, 1-7; doi:10.1016/j.yexmp.2012.01.010 (2012).
12. Lagina, A. T., 3rd et al. Combination therapy with insulin-like growth factor-1 and hypothermia synergistically improves outcome after transient global brain ischemia in the rat. Acad. Emerg. Med. 20, 344-351; doi:10.1111/acem.12104 (2013).
13. Jogie-Brahim, S., Feldman, D. & Oh, Y. Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr. Rev. 30, 417-437; doi:10.1210/er.2008-0028 (2009).
14. Han, J., Jogie-Brahim, S., Harada, A. & Oh, Y. Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF B signaling. Cancer Lett. 307, 200-210; doi:10.1016/j. canlet.2011.04.004 (2011).
15. Zhong, Y. et al. IGF binding protein 3 exerts its ligand-independent action by antagonizing BMP in zebrafish embryos. J. Cell Sci. 124, 1925-1935; doi:10.1242/jcs.082644 (2011).
16. Lee, H. S. et al. Regulation of apoptosis and inflammatory responses by insulin-like growth factor binding protein 3 in fibroblastlike synoviocytes and experimental animal models of rheumatoid arthritis. Arthritis Rheumatol. 66, 863-873; doi:10.1002/art.38303 (2014).
17. Lee, Y. C. et al. Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κ B signaling through IGFBP-3R-mediated activation of caspases. J. Biol. Chem. 286, 17898-17909; doi:10.1074/jbc. M111.231035 (2011).
18. Jaeschke, H. & Lemasters, J. J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125, 1246-1257; doi:10.1016/S0016-5085(03)01209-5 (2003).
19. Lentsch, A. B., Kato, A., Yoshidome, H., McMasters, K. M. & Edwards, M. J. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 32, 169-173; doi:10.1053/jhep.2000.9323 (2000).
20. Funaki, H. et al. Essential role for nuclear factor B in ischemic preconditioning for ischemia-reperfusion injury of the mouse liver. Transplantation 74, 551-556; doi:10.1097/01.TP.0000026580.51510.4E (2002.
21. Henry, S. D. et al. Hypothermic machine preservation reduces molecular markers of ischemia/reperfusion injury in human liver transplantation. Am. J. Transplant. 12, 2477-2486; doi:10.1111/j.1600-6143.2012.04086.x (2012).
22. Yoo, E. G. et al. Insulin-like growth factor-binding protein-3 mediates high glucose-induced apoptosis by increasing oxidative stress in proximal tubular epithelial cells. Endocrinology 152, 3135-3142; doi:10.1210/en.2010-1122 (2011).
23. Yu, H. C. et al. Canonical notch pathway protects hepatocytes from ischemia/reperfusion injury in mice by repressing reactive oxygen species production through JAK2/STAT3 signaling. Hepatology 54, 979-988; doi:10.1002/hep.24469 (2011).
24. Casillas-Ramirez, A. et al. Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury. Endocrinology 150, 3153-3161; doi:10.1210/en.2008-1458 (2009).
25. Pan, S. et al. Protective effects of hydroxytyrosol on liver ischemia/reperfusion injury in mice. Mol. Nutr. Food Res. 57, 1218-1227; doi:10.1002/mnfr.201300010 (2013).
26. Oishi, K. et al. The vitamin E derivative, EPC-K1, suppresses inflammation during hepatic ischemia-reperfusion injury and exerts hepatoprotective effects in rats. J. Surg. Res. 176, 164-170; doi:10.1016/j.jss.2011.03.080 (2012).
27. Duenschede, F. et al. Protection from hepatic ischemia/reperfusion injury and improvement of liver regeneration by a-lipoic acid. Shock 27, 644-651; doi:10.1097/01.shk.0000248582.25647.ee (2007).
28. Xue, Q. et al. Protective role of nitric oxide induced by ischemic preconditioning on cold ischemic-reperfusion injury of rat liver graft. Transplant. Proc. 44, 948-951; doi:10.1016/j.transproceed.2012.01.040 (2012).
29. Behrends, M. et al. Mild hypothermia reduces the inflammatory response and hepatic ischemia/reperfusion injury in rats. Liver Int. 26, 734-741; doi:10.1111/j.1478-3231.2006.01292.x (2006).
30. Kuboki, S. et al. Hepatocyte NF-κ B activation is hepatoprotective during ischemia-reperfusion injury and is augmented by ischemic hypothermia. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G201-207; doi:10.1152/ajpgi.00186.2006 (2007).
31. Bajt, M. L., Ho, Y. S., Vonderfecht, S. L. & Jaeschke, H. Reactive oxygen as modulator of TNF and fas receptor-mediated apoptosis in vivo: studies with glutathione peroxidase-deficient mice. Antioxid. Redox Signal. 4, 733-740; doi:10.1089/152308602760598873 (2002).
32. Dorman, R. B. et al. NAD(P)H oxidase contributes to the progression of remote hepatic parenchymal injury and endothelial dysfunction, but not microvascular perfusion deficits. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1025-1032; doi:10.1152/ajpgi.00246.2005 (2006).
33. Garab, D. et al. Remote ischemic preconditioning differentially affects NADPH oxidase isoforms during hepatic ischemiareperfusion. Life Sci. 105, 14-21; doi:10.1016/j.lfs.2014.04.014 (2014).
34. Hasegawa, T., Malle, E., Farhood, A. & Jaeschke, H. Generation of hypochlorite-modified proteins by neutrophils during ischemia-reperfusion injury in rat liver: attenuation by ischemic preconditioning. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G760-767; doi:10.1152/ajpgi.00141.2005 (2005).
35. Spencer, N. Y. et al. Hepatocytes produce TNF-a following hypoxia-reoxygenation and liver ischemia-reperfusion in a NADPH oxidase-and c-Src-dependent manner. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G84-94; doi:10.1152/ajpgi.00430.2012 (2013).
36. Bae, U. J. et al. SPA0355 attenuates ischemia/reperfusion-induced liver injury in mice. Exp. Mol. Med. 46, e109; doi:10.1038/emm.2014.48 (2014).